METASTATIC HEPATOCELLULAR CARCINOMA
Clinical trials for METASTATIC HEPATOCELLULAR CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC HEPATOCELLULAR CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC HEPATOCELLULAR CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Liver cancer drug combo shows promise but study halted early
Disease control TerminatedThis study tested whether two immunotherapy drugs, nivolumab and ipilimumab, could shrink tumors in people with advanced liver cancer that had already been treated with another drug combination. The trial enrolled 15 adults whose cancer had spread or could not be removed by surge…
Matched conditions: METASTATIC HEPATOCELLULAR CARCINOMA
Phase: PHASE2 • Sponsor: Academic and Community Cancer Research United • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Can an IDO1 inhibitor boost immunotherapy against liver cancer?
Disease control TerminatedThis trial is testing whether combining an experimental IDO1 inhibitor (BMS-986205) with the immunotherapy drug nivolumab can shrink tumors or slow disease progression in people with advanced liver cancer that cannot be surgically removed. The study enrolls adults whose cancer ha…
Matched conditions: METASTATIC HEPATOCELLULAR CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Edward Kim • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC